BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2667 related articles for article (PubMed ID: 7910054)

  • 1. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity.
    Foa R; Norton L; Seidman AD
    Int J Clin Lab Res; 1994; 24(1):6-14. PubMed ID: 7910054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy].
    Fumoleau P; Perrocheau G; Maugard-Louboutin C; Lemevel B
    Bull Cancer; 1995 Aug; 82(8):629-36. PubMed ID: 7492819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Taxoids: structural and experimental properties].
    Lavelle F; Combeau C; Commerçon A
    Bull Cancer; 1995 Apr; 82(4):249-64. PubMed ID: 10846536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxanes: a new class of antitumor agents.
    Huizing MT; Misser VH; Pieters RC; ten Bokkel Huinink WW; Veenhof CH; Vermorken JB; Pinedo HM; Beijnen JH
    Cancer Invest; 1995; 13(4):381-404. PubMed ID: 7627725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel: a review of its pharmacology and clinical activity.
    Trudeau ME
    Can J Oncol; 1996 Jun; 6(1):443-57. PubMed ID: 8853517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.
    Francis PA; Kris MG; Rigas JR; Grant SC; Miller VA
    Lung Cancer; 1995 Apr; 12 Suppl 1():S163-72. PubMed ID: 7551925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxol in ovarian cancer.
    Runowicz CD; Wiernik PH; Einzig AI; Goldberg GL; Horwitz SB
    Cancer; 1993 Feb; 71(4 Suppl):1591-6. PubMed ID: 8094322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
    Verweij J; Clavel M; Chevalier B
    Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New microtubular agents in pediatric oncology.
    Seibel NL; Reaman GH
    Invest New Drugs; 1996; 14(1):49-54. PubMed ID: 8880393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Taxotere: from yew's needles to clinical practice].
    Lavelle F; Gueritte-Voegelein F; Guenard D
    Bull Cancer; 1993 Apr; 80(4):326-38. PubMed ID: 7909695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).
    Pazdur R; Kudelka AP; Kavanagh JJ; Cohen PR; Raber MN
    Cancer Treat Rev; 1993 Oct; 19(4):351-86. PubMed ID: 8106152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paclitaxel (taxol): a review of its antitumor activity and toxicity in clinical studies].
    Yamazaki S; Sekine I; Saijo N
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):605-15. PubMed ID: 9530372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical toxicities encountered with paclitaxel (Taxol).
    Rowinsky EK; Eisenhauer EA; Chaudhry V; Arbuck SG; Donehower RC
    Semin Oncol; 1993 Aug; 20(4 Suppl 3):1-15. PubMed ID: 8102012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The taxoids. Comparative clinical pharmacology and therapeutic potential.
    Eisenhauer EA; Vermorken JB
    Drugs; 1998 Jan; 55(1):5-30. PubMed ID: 9463787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological action of paclitaxel].
    Potemski P; Płuzańska A
    Pol Merkur Lekarski; 1999 Jan; 6(31):27-9. PubMed ID: 10344150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
    Hájek R; Vorlicek J; Slavik M
    Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB; Valero V; Hortobagyi G
    Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The scientific rationale for developing taxoids.
    Aapro M
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of a new tubulin-interacting agent, docetaxel (taxotere) in Japan].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1167-74. PubMed ID: 9239173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The taxoids: paclitaxel and docetaxel.
    Gelmon K
    Lancet; 1994 Nov; 344(8932):1267-72. PubMed ID: 7967989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 134.